<DOC>
	<DOCNO>NCT01748344</DOCNO>
	<brief_summary>The purpose study investigate ONO-4053 relief symptom allergic rhinitis seasonal allergic rhinitis subject expose pollen control condition .</brief_summary>
	<brief_title>Phase II Study Evaluating ONO-4053 Cetirizine Subjects With Seasonal Allergic Rhinitis</brief_title>
	<detailed_description>The purpose study investigate ONO-4053 impact allergic rhinitis symptom subject seasonal allergic rhinitis expose pollen administer fix rate inhalation exposure chamber compare standard treatment Cetirizine 10mg condition .</detailed_description>
	<mesh_term>Rhinitis , Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Rhinitis , Allergic , Seasonal</mesh_term>
	<mesh_term>Cetirizine</mesh_term>
	<criteria>The subject age 18 65 year inclusive , healthy exception allergic rhinitis mild asthma require treatment provide write informed consent , signifies agreement enter study comply restriction requirement list informed consent form . The subject exhibit moderate severe response grass pollen grain allergen challenge chamber Screening . The subject examination find nasal structural abnormality nasal polyp ; history frequent nose bleeds , nasal biopsy , nasal trauma nasal surgery . Pregnant breastfeeding female .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2012</verification_date>
</DOC>